gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
about
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome.Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis.Kinetic analysis of γ-glutamyltransferase reaction process for measuring activity via an integration strategy at low concentrations of γ-glutamyl p-nitroaniline.Review of current clinical biomarkers for the detection of alcohol dependenceComparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia.Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis.Inflammation as a cardiovascular risk factor and pulse wave velocity as a marker of early-stage atherosclerosis in the Japanese populationEvaluation of arterial stiffness with plasma GGT levels and pulse wave velocity measurement in patients with FMF.Use of oral N-acetylcysteine for protection of melanocytic nevi against UV-induced oxidative stress: towards a novel paradigm for melanoma chemoprevention.From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?The usefulness of γ-glutamyltransferase as a marker of cardiovascular function in Africans and Caucasians: the SABPA study.Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuria.Serum γ-glutamyltranspeptidase and oxidative stress in subjectively healthy women: an association with menopausal stages.Gamma-glutamyltransferase, possible novel biomarker in colon diverticulosis: a case-control study.Serum gamma-glutamyltransferase is associated with arterial stiffness in healthy individuals.Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis.γ-Glutamyl transferase activity and the burden of coronary atherosclerosis in patients with ST-segment elevation myocardial infarction.Association between Liver Enzymes with Metabolically Unhealthy Obese PhenotypePlasma Aminothiol Profile and Some of Its Determinants in Apparently Healthy Azorean Subjects
P2860
Q34043671-064F7157-3EDC-43A5-A8DD-72E57C5DA5F8Q34311151-CECCB558-28FA-45FB-8889-9E37278FB62EQ34625378-1BBCD8F9-1FCA-498E-87D9-23352319F4A9Q34779689-A67225C8-4BC0-432A-B7D5-10D789EF796CQ36521938-10270257-F0D0-48E3-94EA-5EBF50C3FD3CQ37139481-D67D38AB-428E-4088-8B0F-F9A71044B270Q37198826-A2DE43FB-91B9-4B6D-B0DE-27EE87BDC079Q37296436-7EE2C91A-5044-42A8-980D-4834D68A0594Q37455927-4AE40AD8-6C90-4624-9DD8-7D35BC55E5D9Q42550368-ACD1C587-08BD-4F80-9705-07B3B405185AQ44066054-14C15884-C964-4A41-B325-525F0DAC91E5Q45083212-E7E326DC-9F09-4752-A889-9BEC322ED847Q46659546-4C35AA1B-9254-4F13-9921-C3B7301A0D4FQ48160338-1E0CFFD5-FB68-42A9-B5C7-62871C1059BCQ51374423-27440717-05EA-46DF-AE37-396ADF9859DCQ51447981-29139987-F1FC-4FD6-B44D-027F7DA2684FQ54691193-1D9DF289-41C8-42F8-99E7-AA205A2BC68CQ58716186-562E2DB3-9948-4B42-AD86-CCE2CEC69D51Q59049958-FAB65B20-48DE-4D35-9083-88C08A17ACB8
P2860
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@ast
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@en
type
label
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@ast
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@en
prefLabel
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@ast
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk.
@en
P2093
P1433
P1476
gamma-Glutamyltransferase is a promising biomarker for cardiovascular risk
@en
P2093
Filiz Karadas
Kenan Yalta
M Birhan Yilmaz
P304
P356
10.1016/J.MEHY.2006.04.010
P577
2006-08-07T00:00:00Z